IATDMCT 2017

出展者情報

[3] AstraZeneca K.K.

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Oncology, Cardiovascular & Metabolic Diseases and Respiratory. The Company also is selectively active in the areas of autoimmunity, neuroscience and infection. We are seeking to collaborate with investigators and clinicians across all stages of drug discovery from innovative early ideas through clinical validation by Open Innovation platform which offers access to optimised compounds, compound libraries, technologies, services and know-how, and the opportunity to develop your ideas into treatments for patients.